Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Nicoll

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|May 1, 2018
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis CStephen Bloom, William Kemp, Amanda Nicoll, et al.
Scandinavian Journal of Gastroenterology|January 24, 2015
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian studyIlana Gory, Michael Fink, Sally Bell, et al.
Gut|February 28, 2013
Hepatic macrophage activation predicts clinical decompensation in chronic liver diseaseAnthony Rode, Amanda Nicoll, Holger Jon Møller, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2016
Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapyLucy Lim, Alexander Thompson, Scott Patterson, et al.
The Medical Journal of Australia|January 26, 2020
Survival of patients with ruptured and non-ruptured hepatocellular carcinomaNatassia P Tan, Ammar Majeed, Stuart K Roberts, et al.
Journal of Gastroenterology and Hepatology|November 7, 2019
Increasing prevalence of primary biliary cholangitis in Victoria, AustraliaJanine French, Ingrid van der Mei, Steve Simpson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 10, 2015
Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaKonstantin Kazankov, Anthony Rode, Kira Simonsen, et al.
Scandinavian Journal of Gastroenterology|November 6, 2018
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalStuart K Roberts, Alessia Gazzola, John Lubel, et al.
Hepatology Communications|April 27, 2023
Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary surveyNatasha Janko, Ammar Majeed, Warren Clements, et al.
Journal of Gastroenterology and Hepatology|August 28, 2015
Circulating CD147 predicts mortality in advanced hepatocellular carcinomaAimei Lee, Anthony Rode, Amanda Nicoll, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|May 1, 2018
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis CStephen Bloom, William Kemp, Amanda Nicoll, et al.
Scandinavian Journal of Gastroenterology|January 24, 2015
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian studyIlana Gory, Michael Fink, Sally Bell, et al.
Gut|February 28, 2013
Hepatic macrophage activation predicts clinical decompensation in chronic liver diseaseAnthony Rode, Amanda Nicoll, Holger Jon Møller, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2016
Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapyLucy Lim, Alexander Thompson, Scott Patterson, et al.
The Medical Journal of Australia|January 26, 2020
Survival of patients with ruptured and non-ruptured hepatocellular carcinomaNatassia P Tan, Ammar Majeed, Stuart K Roberts, et al.
Journal of Gastroenterology and Hepatology|November 7, 2019
Increasing prevalence of primary biliary cholangitis in Victoria, AustraliaJanine French, Ingrid van der Mei, Steve Simpson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 10, 2015
Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaKonstantin Kazankov, Anthony Rode, Kira Simonsen, et al.
Scandinavian Journal of Gastroenterology|November 6, 2018
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalStuart K Roberts, Alessia Gazzola, John Lubel, et al.
Hepatology Communications|April 27, 2023
Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary surveyNatasha Janko, Ammar Majeed, Warren Clements, et al.
Journal of Gastroenterology and Hepatology|August 28, 2015
Circulating CD147 predicts mortality in advanced hepatocellular carcinomaAimei Lee, Anthony Rode, Amanda Nicoll, et al.
Pageof 6